Healthequity Inc (NASDAQ: HQY) has seen a rise in its stock price by 2.20 in relation to its previous close of 95.70. However, the company has experienced a -1.02% decline in its stock price over the last five trading sessions. zacks.com reported 2024-11-14 that HQY’s sustained strength in HSAs raises optimism about the stock.
Is It Worth Investing in Healthequity Inc (NASDAQ: HQY) Right Now?
The price-to-earnings ratio for Healthequity Inc (NASDAQ: HQY) is 81.49x, which is above its average ratio. Moreover, the 36-month beta value for HQY is 0.52. Analysts have varying opinions on the stock, with 7 analysts rating it as a “buy,” 6 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for HQY is 85.28M and currently, short sellers hold a 4.92% of that float. On November 15, 2024, HQY’s average trading volume was 587.40K shares.
HQY’s Market Performance
HQY stock saw an increase of -1.02% in the past week, with a monthly gain of 11.15% and a quarterly increase of 29.17%. The volatility ratio for the week is 3.11%, and the volatility levels for the last 30 days are 2.75% for Healthequity Inc (HQY). The simple moving average for the last 20 days is 6.88% for HQY stock, with a simple moving average of 20.88% for the last 200 days.
Analysts’ Opinion of HQY
JMP Securities, on the other hand, stated in their research note that they expect to see HQY reach a price target of $101. The rating they have provided for HQY stocks is “Mkt Outperform” according to the report published on April 04th, 2024.
JP Morgan gave a rating of “Overweight” to HQY, setting the target price at $108 in the report published on April 02nd of the current year.
HQY Trading at 15.08% from the 50-Day Moving Average
After a stumble in the market that brought HQY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.32% of loss for the given period.
Volatility was left at 2.75%, however, over the last 30 days, the volatility rate increased by 3.11%, as shares surge +11.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +28.25% upper at present.
During the last 5 trading sessions, HQY fell by -1.06%, which changed the moving average for the period of 200-days by +29.30% in comparison to the 20-day moving average, which settled at $91.51. In addition, Healthequity Inc saw 47.53% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HQY starting from Corvino Frank, who sale 1,039 shares at the price of $96.10 back on Nov 06 ’24. After this action, Corvino Frank now owns 3,784 shares of Healthequity Inc, valued at $99,848 using the latest closing price.
SELANDER ROBERT W, the Director of Healthequity Inc, sale 8,250 shares at $82.98 during a trade that took place back on Oct 09 ’24, which means that SELANDER ROBERT W is holding 54,719 shares at $684,578 based on the most recent closing price.
Stock Fundamentals for HQY
Current profitability levels for the company are sitting at:
- 0.16 for the present operating margin
- 0.58 for the gross margin
The net margin for Healthequity Inc stands at 0.1. The total capital return value is set at 0.05. Equity return is now at value 5.15, with 3.21 for asset returns.
Based on Healthequity Inc (HQY), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at 0.28. The debt to equity ratio resting at 0.52. The interest coverage ratio of the stock is 3.24.
Currently, EBITDA for the company is 282.42 million with net debt to EBITDA at 2.42. When we switch over and look at the enterprise to sales, we see a ratio of 8.51. The receivables turnover for the company is 10.13for trailing twelve months and the total asset turnover is 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.10.
Conclusion
To wrap up, the performance of Healthequity Inc (HQY) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
